T. Rowe Price Associates’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,601
| Closed | -$26K | – | 3097 |
|
|
2025
Q1 | $26K | Buy |
+15,601
| New | +$26K | ﹤0.01% | 2988 |
|
|
2024
Q4 | – | Sell |
-20,652
| Closed | -$120K | – | 3024 |
|
|
2024
Q3 | $120K | Hold |
20,652
| – | – | ﹤0.01% | 2784 |
|
|
2024
Q2 | $167K | Buy |
20,652
+8,153
| +65% | +$65.9K | ﹤0.01% | 2631 |
|
|
2024
Q1 | $174K | Sell |
12,499
-137,501
| -92% | -$1.91M | ﹤0.01% | 2660 |
|
|
2023
Q4 | $77K | Hold |
150,000
| – | – | ﹤0.01% | 2750 |
|
|
2023
Q3 | $59K | Buy |
150,000
+68,500
| +84% | +$26.9K | ﹤0.01% | 2750 |
|
|
2023
Q2 | $37K | Sell |
81,500
-44,665
| -35% | -$20.3K | ﹤0.01% | 2828 |
|
|
2023
Q1 | $104K | Buy |
126,165
+30,566
| +32% | +$25.2K | ﹤0.01% | 2680 |
|
|
2022
Q4 | $149K | Sell |
95,599
-23,873
| -20% | -$37.2K | ﹤0.01% | 2619 |
|
|
2022
Q3 | $207K | Sell |
119,472
-9,012
| -7% | -$15.6K | ﹤0.01% | 2528 |
|
|
2022
Q2 | $222K | Buy |
128,484
+2,878
| +2% | +$4.97K | ﹤0.01% | 2552 |
|
|
2022
Q1 | $451K | Buy |
125,606
+10,564
| +9% | +$37.9K | ﹤0.01% | 2377 |
|
|
2021
Q4 | $574K | Sell |
115,042
-48,750
| -30% | -$243K | ﹤0.01% | 2317 |
|
|
2021
Q3 | $1.17M | Buy |
163,792
+8,500
| +5% | +$60.9K | ﹤0.01% | 1968 |
|
|
2021
Q2 | $1.44M | Buy |
155,292
+9,477
| +6% | +$87.9K | ﹤0.01% | 1887 |
|
|
2021
Q1 | $1.35M | Sell |
145,815
-11,169
| -7% | -$104K | ﹤0.01% | 1893 |
|
|
2020
Q4 | $1.39M | Buy |
156,984
+72,307
| +85% | +$640K | ﹤0.01% | 1787 |
|
|
2020
Q3 | $982K | Buy |
84,677
+22,005
| +35% | +$255K | ﹤0.01% | 1797 |
|
|
2020
Q2 | $1.69M | Buy |
62,672
+21,312
| +52% | +$574K | ﹤0.01% | 1587 |
|
|
2020
Q1 | $308K | Buy |
41,360
+23,026
| +126% | +$171K | ﹤0.01% | 2181 |
|
|
2019
Q4 | $61K | Buy |
18,334
+3,693
| +25% | +$12.3K | ﹤0.01% | 2483 |
|
|
2019
Q3 | $30K | Buy |
14,641
+929
| +7% | +$1.9K | ﹤0.01% | 2492 |
|
|
2019
Q2 | $40K | Hold |
13,712
| – | – | ﹤0.01% | 2515 |
|
|
2019
Q1 | $51K | Buy |
13,712
+100
| +0.7% | +$372 | ﹤0.01% | 2497 |
|
|
2018
Q4 | $54K | Buy |
13,612
+164
| +1% | +$651 | ﹤0.01% | 2504 |
|
|
2018
Q3 | $75K | Buy |
13,448
+501
| +4% | +$2.79K | ﹤0.01% | 2535 |
|
|
2018
Q2 | $51K | Buy |
12,947
+88
| +0.7% | +$347 | ﹤0.01% | 2554 |
|
|
2018
Q1 | $61K | Buy |
12,859
+2,659
| +26% | +$12.6K | ﹤0.01% | 2512 |
|
|
2017
Q4 | $42K | Hold |
10,200
| – | – | ﹤0.01% | 2532 |
|
|
2017
Q3 | $65K | Hold |
10,200
| – | – | ﹤0.01% | 2517 |
|
|
2017
Q2 | $80K | Hold |
10,200
| – | – | ﹤0.01% | 2501 |
|
|
2017
Q1 | $68K | Buy |
+10,200
| New | +$68K | ﹤0.01% | 2522 |
|